DrugPipeline.net has announced the addition of “Celiac Disease (CD) - Epidemiology Insights-2023- EU5” research report to their website DrugPipeline.net
Bangalore, Karnataka -- (SBWIRE) -- 12/19/2016 -- "Celiac Disease (CD) - Epidemiology Insights-2023- EU5" report provides an overview of the Celiac Disease and current scenario of the disease in the EU5 countries (France, Germany, Italy, Spain and UK)). It also includes historical and forecasted epidemiological data for the total prevalent and diagnosed prevalent cases of Celiac Disease in EU5 from 2013-2023.
Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The number of ways celiac disease can affect patients, combined with a lack of training in medical schools and primary care residency programs, contributes to the poor diagnosis rate. Currently it is estimated that 80% of the celiac disease population remains undiagnosed. Prevalence in Western Europe ranges between 1 in 133. It is higher in relatives of people with celiac disease. Women are affected more commonly than men, but there is no age predilection.
Report forecasts predict that the total prevalent cases of Celiac Disease in EU5 is expected to accentuate up to 3.2 Million by 2023 at a Compound Annual Growth Rate (CAGR) of 2.21% from 2013-2023, while the diagnosed prevalent population of Celiac Disease shall grow at a CAGR of 2.86% for the forecast period (2013-2023).
- Report covers the disease overview including pathophysiology, symptoms, diagnosis and disease management.
- It focuses on the detailed historical number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for EU5 countries from 2013-2015.
- The report also includes forecasted number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for EU5 countries from 2016-2023.
Spanning over 60 pages "Celiac Disease (CD) - Epidemiology Insights-2023- EU5" report covers Celiac Disease Overview, Disease Management, Treatment of Celiac Disease, Appendix, Report Methodology
For more information Visit at: http://www.drugpipeline.net/delveinsight/celiac-disease-cd-epidemiology-insights-2023-eu5
Glomerulonephritis - Epidemiology Forecast To 2023; visit - http://www.drugpipeline.net/delveinsight/glomerulonephritis-epidemiology-forecast-2023
Cushing's Syndrome - Epidemiology Forecast To 2023; visit - http://www.drugpipeline.net/delveinsight/cushings-syndrome%C2%A0-epidemiology-forecast-2023
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.